Envestnet Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.25M | Buy |
|
|||||
|
2025
Q2 | $974K | Buy |
|
|||||
|
2025
Q1 | $977K | Sell |
|
|||||
|
2024
Q4 | $1.24M | Sell |
|
|||||
|
2024
Q3 | $1.75M | Buy |
|
|||||
|
2024
Q2 | $1.66M | Buy |
|
|||||
|
2024
Q1 | $1.72M | Buy |
|
|||||
|
2023
Q4 | $1.73M | Sell |
|
|||||
|
2023
Q3 | $824K | Buy |
|
|||||
|
2023
Q2 | $682K | Sell |
|
|||||
|
2023
Q1 | $751K | Buy |
|
|||||
|
2022
Q4 | $975K | Sell |
|
|||||
|
2022
Q3 | $1.15M | Sell |
|
|||||
|
2022
Q2 | $944K | Buy |
|
|||||
|
2022
Q1 | $730K | Buy |
|
|||||
|
2021
Q4 | $839K | Buy |
|
|||||
|
2021
Q3 | $563K | Sell |
|
|||||
|
2021
Q2 | $405K | Buy |
|
|||||
|
2021
Q1 | $437K | Buy |
|
|||||
|
2020
Q4 | $247K | Sell |
|
|||||
|
2020
Q3 | $295K | Buy |
|
|||||
|
2020
Q2 | $300K | Sell |
|
|||||
|
2020
Q1 | $237K | Buy |
|